+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site

Crystal structure and pharmacological characterization of a novel N-methyl-D-aspartate (NMDA) receptor antagonist at the GluN1 glycine binding site

Journal of Biological Chemistry 288(46): 33124-33135

NMDA receptors are ligand-gated ion channels that mediate excitatory neurotransmission in the brain. They are tetrameric complexes composed of glycine-binding GluN1 and GluN3 subunits together with glutamate-binding GluN2 subunits. Subunit-selective antagonists that discriminate between the glycine sites of GluN1 and GluN3 subunits would be valuable pharmacological tools for studies on the function and physiological roles of NMDA receptor subtypes. In a virtual screening for antagonists that exploit differences in the orthosteric binding site of GluN1 and GluN3 subunits, we identified a novel glycine site antagonist, 1-thioxo-1,2-dihydro-[1,2,4]triazolo[4,3-a]quinoxalin-4(5H)-one (TK40). Here, we show by Schild analysis that TK40 is a potent competitive antagonist with Kb values of 21-63 nM at the GluN1 glycine-binding site of the four recombinant GluN1/N2A-D receptors. In addition, TK40 displayed >100-fold selectivity for GluN1/N2 NMDA receptors over GluN3A- and GluN3B-containing NMDA receptors and no appreciable effects at AMPA receptors. Binding experiments on rat brain membranes and the purified GluN1 ligand-binding domain using glycine site GluN1 radioligands further confirmed the competitive interaction and high potency. To delineate the binding mechanism, we have solved the crystal structure of the GluN1 ligand-binding domain in complex with TK40 and show that TK40 binds to the orthosteric binding site of the GluN1 subunit with a binding mode that was also predicted by virtual screening. Furthermore, the structure reveals that the imino acetamido group of TK40 acts as an α-amino acid bioisostere, which could be of importance in bioisosteric replacement strategies for future ligand design.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 052396245

Download citation: RISBibTeXText

PMID: 24072709

DOI: 10.1074/jbc.m113.480210

Related references

Characterization of the binding of [3H]L-689,560, an antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes. Molecular Pharmacology 41(5): 923-930, 1992

Effects of L-701,324, a high-affinity antagonist at the N-methyl-D-aspartate (NMDA) receptor glycine site on the rat electroencephalogram. Naunyn Schmiedeberg's Archives of Pharmacology 355(6): 779-786, 1997

The N-methyl-D-aspartate (NMDA) receptor glycine site antagonist ACEA 1021 does not produce pathological changes in rat brain. Brain Research 744(2): 227-234, 1997

Effects of L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor, on the electroencephalogram and NMDA-evoked responses in the rat striatum. British Journal of Pharmacology 117(PROC Suppl. ): 26P, 1996

In vitro pharmacological properties of the N-methyl-D-aspartate receptor glycine site antagonist, SM-18400. Society for Neuroscience Abstracts 24(1-2): 574, 1998

Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. European Journal Of Pharmacology. 323(2-3): 181-192, 1997

A novel glycine site-specific N-methyl-D-aspartate receptor antagonist prevents activation of the NMDA/NO/CGMP pathway by ammonia. Brain Research 1015(1-2): 186-188, 2004

Binding affinity of some herbal extracts on the glycine binding site of NMDA (N-methyl-D-aspartate) receptor. Korean Journal of Pharmacognosy 32(3): 212-218, 2001

Novel structure having antagonist actions at both the glycine site of the N-methyl-D-aspartate receptor and neuronal voltage-sensitive sodium channels: biochemical, electrophysiological, and behavioral characterization. Journal of Pharmacology and Experimental Therapeutics 292(1): 215-227, 2000

Pharmacological properties of SM-31900, a novel NMDA receptor glycine-binding site antagonist. Japanese Journal of Pharmacology 82(Suppl 1): 109P, 2000

Identification of AICP as a GluN2C-Selective N -Methyl-d-Aspartate Receptor Superagonist at the GluN1 Glycine Site. Molecular Pharmacology 92(2): 151-161, 2017

Inhibition of n methyl d aspartate nmda evoked neurotransmitter release by the glycine antagonist ha 966 evidence for the modulation of strychnine insensitive glycine sites associated with the nmda receptor ionophore complex. FASEB Journal 3(4): A1293, 1989

Pharmacological characterization of MDL 105,519, a systemically active antagonist of the NMDA receptor-associated glycine recognition site. Society for Neuroscience Abstracts 21(1-3): 1106, 1995

Effects of taurine on modulation of tritiated mk 801 binding the n methyl d aspartate nmda receptor complex by l glutamate nmda l aspartate and glycine. Anatomical Record 226(4): 114A, 1990

Cleavage of the NR2B subunit amino terminus of N-methyl-D-aspartate (NMDA) receptor by tissue plasminogen activator: identification of the cleavage site and characterization of ifenprodil and glycine affinities on truncated NMDA receptor. Journal of Biological Chemistry 287(30): 25520-9, 2012